Paper90553
Multiple new phenotypes induced in 10T1/2 and 3T3 cells treated with 5-azacytidine.
Taylor SM and 1 other. Cell, 1979. Cited by 1,006 papers, by iCite.
Cite this record
ConductScience Library. Multiple new phenotypes induced in 10T1/2 and 3T3 cells treated with 5-azacytidine. Papers, record 90553. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/90553
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Azacitidine | Major topic |
| Cell Differentiation | Major topic |
| Adipose Tissue | |
| Animals | |
| Cartilage | |
| Cell Line | |
| Cell Transformation, Neoplastic | |
| Clone Cells | |
| Embryo, Mammalian | |
| Mice | |
| Muscles | |
| Phenotype |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 21102604 | From MYOD1 to iPS cells. | https://conductscience.org/library/papers/21102604 |
Source PubMed
Cited by325
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,006 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42925407 | Decitabine and azacitidine exert multifaceted effects beyond DNA hypomethylation in myeloid neoplasms. | Int J Hematol | 2026 | https://conductscience.org/library/papers/42925407 | PubMed |
| 42895683 | Epigenetics in development, disease, and therapy: from mechanisms to clinical interventions. | Sci China Life Sci | 2026 | https://conductscience.org/library/papers/42895683 | PubMed |
| 42769310 | Brown Adipose Tissue: Molecular Mechanisms of Regulation, Physiological Functions, and Therapeutic Targets. | MedComm (2020) | 2026 | https://conductscience.org/library/papers/42769310 | PubMed |
| 42682758 | Decellularized testicular bio-scaffolds drive in vitro differentiation of chemically reprogrammed fibroblasts. | Front Bioeng Biotechnol | 2026 | https://conductscience.org/library/papers/42682758 | PubMed |
| 42316346 | Screening and identification of the ncRNA-mRNA regulatory network associated with DNA methylation in goose embryonic myoblasts. | BMC Genomics | 2026 | https://conductscience.org/library/papers/42316346 | PubMed |
| 42196535 | Recent Advances in Searching for DNMT Inhibitors and Their Potential Application in Treating Human Diseases. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42196535 | PubMed |
| 41146328 | TET exhibits enzymatic-independent and-dependent functions during Drosophila flight muscle development and aging. | Skelet Muscle | 2025 | https://conductscience.org/library/papers/41146328 | PubMed |
| 41107536 | Redefining cellular reprogramming with advanced genomic technologies. | Nat Rev Genet | 2026 | https://conductscience.org/library/papers/41107536 | PubMed |
| 41044248 | Dissecting the impact of transcription factor dose on cell reprogramming heterogeneity using scTF-seq. | Nat Genet | 2025 | https://conductscience.org/library/papers/41044248 | PubMed |
| 40934713 | Effects of DNMT1 and TET2 on proliferation and differentiation of goose embryonic myoblasts. | Poult Sci | 2025 | https://conductscience.org/library/papers/40934713 | PubMed |
| 40853551 | Advances in fibroblast-based cardiac reprogramming in the treatment of heart disease. | Inflamm Res | 2025 | https://conductscience.org/library/papers/40853551 | PubMed |
| 40683107 | Cell and tissue reprogramming: Unlocking a new era in medical drug discovery. | Pharmacol Rev | 2025 | https://conductscience.org/library/papers/40683107 | PubMed |
| 39812007 | DNA methylation patterns are influenced by Pax3::Foxo1 expression and developmental lineage in rhabdomyosarcoma tumours forming in genetically engineered mouse models. | J Pathol | 2025 | https://conductscience.org/library/papers/39812007 | PubMed |
| 39734197 | Shedding light on DNA methylation and its clinical implications: the impact of long-read-based nanopore technology. | Epigenetics Chromatin | 2024 | https://conductscience.org/library/papers/39734197 | PubMed |
| 39474325 | Environmental Obesogens and Their Perturbations in Lipid Metabolism. | Environ Health (Wash) | 2024 | https://conductscience.org/library/papers/39474325 | PubMed |
| 39143643 | Lesson on obesity and anatomy of adipose tissue: new models of study in the era of clinical and translational research. | J Transl Med | 2024 | https://conductscience.org/library/papers/39143643 | PubMed |
| 39132254 | Bioengineering-tissue strategies to model mammalian implantation in vitro. | Front Bioeng Biotechnol | 2024 | https://conductscience.org/library/papers/39132254 | PubMed |
| 38886411 | Cancer-associated Histone H3 N-terminal arginine mutations disrupt PRC2 activity and impair differentiation. | Nat Commun | 2024 | https://conductscience.org/library/papers/38886411 | PubMed |
| 38509259 | Molecular Basis of Cell Reprogramming into iPSCs with Exogenous Transcription Factors. | Results Probl Cell Differ | 2024 | https://conductscience.org/library/papers/38509259 | PubMed |
| 38302581 | Canalizing cell fate by transcriptional repression. | Mol Syst Biol | 2024 | https://conductscience.org/library/papers/38302581 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/90553
GET https://conductscience.org/api/papers/v1/90553/cited_by?page=2